Deep Learning-Enabled Multi-Omics Integration: A New Frontier in Precise Drug Target Discovery

Area of Science:

• Computational Biology
• Genomics
• Pharmacology

Background:

• Pharmaceutical R&D faces high costs and attrition due to complex diseases.
• Single-omics methods struggle to capture systemic disease complexity.
• Deep learning (DL) offers advanced multi-omics integration for drug discovery.

Purpose of the Study:

• To review advancements in DL-driven multi-omics integration for drug target discovery.
• To explore DL architectures and integration strategies for multi-omics data.
• To examine the efficacy of DL in identifying disease drivers and therapeutic targets.

Main Methods:

• Systematic review of DL applications in multi-omics integration.
• Delineation of multi-omics data foundations and integration strategies.
• Exploration of DL architectures (e.g., CNNs, RNNs, GNNs) for omics data processing.

Main Results:

• DL effectively integrates multi-omics data for identifying novel disease drivers.
• DL aids in predicting synthetic lethality interactions for targeted therapies.
• DL enhances the prioritization of potential therapeutic targets.

Conclusions:

• DL-driven multi-omics integration is a powerful tool for precision drug discovery.
• Addressing challenges like data sparsity and interpretability is crucial.
• Emerging AI technologies (Generative AI, LMMs, XAI) offer future opportunities.